The Cancer Letter

Inside information on cancer research and drug development

In Brief

George W. Bush headlines $26 million fundraiser for Inova

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Former President George W. Bush and former White House advisor Karl Rove helped raise more than $26 million for the Inova Schar Cancer Institute, setting a new record for a single-event non-profit fundraiser in the Washington, D.C., region.

The donations will help support a new highly personalized cancer research and treatment center on a 117-acre campus.

The fundraising dinner, held at the Inova Center for Personalized Health and chaired by NVR, Inc. president and chief executive officer Paul Saville and his wife Linda, drew more than 225 guests.

Former President Bush, who was interviewed by his former advisor at the event, has made the fight against cancer one of the priorities of his post-presidential activities.

The Inova Schar Cancer Institute got its start in 2015, when Dwight Schar, Chairman of the Board of NRV Inc., and his wife Martha, made a $50 million gift to Inova, the largest in the health system’s history. The institute will move into a new facility on the campus of the Inova Center for Personalized Health in Falls Church, Virginia, in April 2019.

Table of Contents

YOU MAY BE INTERESTED IN

Obituary

Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
By Melinda Krigel
Obituary

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
By NRG Staff
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account